Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)

The summary for the Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)
	CFDA Number:	93.838
	CFDA Description:	Lung Diseases Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PA-06-076
	Document Type:	Modification to Previous Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Nov 18, 2005
	Creation Date:	Dec 12, 2006
	Original Closing Date for Applications:	Multiple Receipt Dates - See Link to Full Announcement for details.
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Feb 03, 2007
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification) Small businesses Public and State controlled institutions of higher education Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses County governments State governments City or township governments Independent school districts Special district governments Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply.
Grant Description: Completion of the Human Genome Project and technological advances now make it possible to probe the molecular pathology of rare and common pulmonary diseases associated with disorders in membrane trafficking pathways. The National Heart, Lung, and Blood Institute invites research grant applications to delineate the protein interactions and pathways governing membrane trafficking pathways operative in pulmonary health and disease and develop novel therapeutic interventions.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PA-06-076.html http://grants.nih.gov/grants/guide/pa-files/PA-06-076.html
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
Similar Government Grants: • Short-Term Institutional Training Grant for Clinician Scientists in Pediatric Respiratory, Sleep and...; • Phase II Clinical Trials of Novel Therapies for Lung Diseases (UM1); • Development and Testing of a Case Finding Methodology in COPD (R01); • Maximizing the Scientific Value of the NHLBI Biologic Specimen Repository: Scientific Opportunities ...; • Genomic Research in AAT-Deficiency and Sarcoidosis study (GRADS) Cooperative Research Project Grant:...; • PATHOGENESIS OF SARS LUNG DISEASE: IN VITRO STUDIES AND ANIMAL MODELS; • Lung Response to Inhaled Highly Toxic Chemicals; • ASTHMA CLINICAL RESEARCH NETWORK; • COPD CLINICAL RESEARCH NETWORK; • NONHUMAN PRIMATE MODELS OF HIV-ASSOCIATED PULMONARY, CARDIOVASCULAR, AND HEMATOLOGICAL DISORDERS